Does BPC-157 actually work?

In rodents the healing data are consistent and genuinely impressive across tendon, ligament, muscle and gut models, and community reports are widely positive. Completed human trials don't exist yet, so the honest summary is: strong preclinical signal, not yet quantified in humans.

It is not an approved medicine or a lawful dietary supplement in the US, and sale for human use is restricted in the UK. In Australia it became Schedule 4 (prescription-only) in 2024.

Is BPC-157 banned by WADA?

It is not currently listed by name, but the position can change and other tissue-repair peptides are prohibited; verify before competing.

Back to library

BPC-157

Animal / preclinical

Also known as: Body Protection Compound 157

Healing & recoverySoft-tissue recovery (claimed)Gut health (claimed)

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

A synthetic fragment of a gastric protective protein and one of the most popular recovery peptides. Rodent studies consistently show accelerated healing of tendon, ligament, muscle and gut tissue — the basis for widespread community use — while human trials have yet to be completed.

Mechanism

Promotes angiogenesis and modulates growth-factor and nitric-oxide pathways in animal models, which is the proposed route to faster tissue repair. Human mechanism remains to be confirmed.

Evidence

Animal / preclinicalWhat does this mean?

Consistent, promising rodent data across tendon, ligament and GI models; human RCTs have not yet been completed, so human efficacy and safety are unquantified.

Community-reported information

Community discussions report a range of microgram-to-milligram daily amounts. This is anecdotal, unvalidated, and shown as general information only — not advice.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

Short (hours); not well characterised in humans.

Storage

Lyophilised: refrigerate. Reconstituted: refrigerate, use within weeks.

Commonly reported side effects

Not well characterised in humans
Injection-site reactions reported anecdotally

Legal status by region

USNot FDA-approved; not a dietary supplement. FDA flagged for compounding restrictions.
GBNot licensed for human use; sale for human use restricted.
AUSchedule 4 (prescription-only) since June 2024.

Legal status changes over time; verify locally before relying on this.

Frequently asked questions

Does BPC-157 actually work?: In rodents the healing data are consistent and genuinely impressive across tendon, ligament, muscle and gut models, and community reports are widely positive. Completed human trials don't exist yet, so the honest summary is: strong preclinical signal, not yet quantified in humans.
Is BPC-157 legal?: It is not an approved medicine or a lawful dietary supplement in the US, and sale for human use is restricted in the UK. In Australia it became Schedule 4 (prescription-only) in 2024.
Is BPC-157 banned by WADA?: It is not currently listed by name, but the position can change and other tissue-repair peptides are prohibited; verify before competing.

Citations

BPC-157 preclinical literaturePubMed